Article
Selecta's (SELB) Gene Therapy Gets Rare Pediatric Disease Tag
Rating:
0.0
Views:
99
Likes:
1
Library:
1
The FDA bestows a Rare Pediatric Disease status on Selecta's (SELB) gene therapy candidate MMA-101, which is being developed for the treatment of isolated methylmalonic acidemia.
Rate This Post
-
Education
-
Communication
-
Entertainment
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value